Cancer treatment-induced bone loss (CTIBL): Pathogenesis and clinical implications
详细信息 查看全文
- 作者：S. D&rsquo ; Oronzo ester86d@gmail.com" class="auth_mail" title="E-mail the corresponding author ; S. Stucci stuccistefania@gmail.com" class="auth_mail" title="E-mail the corresponding author ; M. Tucci marco.tucci@uniba.it" class="auth_mail" title="E-mail the corresponding author ; F. Silvestris ; francesco.silvestris@uniba.it" class="auth_mail" title="E-mail the corresponding author
- 关键词：Cancer treatments ; Bone loss ; BMD ; Osteoblast ; Osteoclast
- 刊名：Cancer Treatment Reviews
- 出版年：2015
- 出版时间：November 2015
- 年：2015
- 卷：41
- 期：9
- 页码：798-808
- 全文大小：1624 K
文摘
- •
Long-term cancer treatments promote bone loss in neoplastic patients.
- •
Osteopenia favors the cancer cell nesting in bone.
- •
Bone health impairment compromises the quality of life with negative social impact.
- •
CTIBL should be periodically assessed in patients undergoing cancer treatments.